When radiopharmaceutical production facilities irradiate uranium targets for the production of radionuclides such as 99Mo, the emissions interfere with the global monitoring efforts conducted by the Comprehensive Nuclear-Test-Ban Treaty Organization. While suppressing emissions from such facilities would be ideal, it is understood that radioxenon emissions may not be reduced to levels below detectable quantities. As a result, a study was conducted to investigate tracers that may be utilized for source identification upon measurement. Both radioactive and stable tracers were evaluated.
Revised: August 26, 2016 |
Published: April 1, 2013
Citation
Biegalski S.R., T.W. Bowyer, and D.A. Haas. 2013.Tracers for radiopharmaceutical production facilities.Journal of Radioanalytical and Nuclear Chemistry 296, no. 1:477-482.PNNL-SA-99101.doi:10.1007/s10967-012-1967-8